SCATTOLIN, THOMAS
 Distribuzione geografica
Continente #
NA - Nord America 6.490
EU - Europa 4.175
AS - Asia 2.592
SA - Sud America 252
AF - Africa 59
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 7
Totale 13.583
Nazione #
US - Stati Uniti d'America 6.291
PL - Polonia 2.199
CN - Cina 1.118
SG - Singapore 835
IT - Italia 716
DE - Germania 246
BR - Brasile 211
HK - Hong Kong 204
UA - Ucraina 201
IE - Irlanda 168
CA - Canada 163
GB - Regno Unito 142
SE - Svezia 118
RU - Federazione Russa 114
VN - Vietnam 89
IN - India 75
FR - Francia 73
FI - Finlandia 70
ID - Indonesia 59
JP - Giappone 55
TR - Turchia 43
KR - Corea 38
MX - Messico 27
BE - Belgio 26
AR - Argentina 22
AT - Austria 22
CH - Svizzera 19
MA - Marocco 19
ES - Italia 18
IQ - Iraq 14
BD - Bangladesh 12
NL - Olanda 10
ZA - Sudafrica 10
IR - Iran 9
BJ - Benin 8
PH - Filippine 8
BG - Bulgaria 7
EU - Europa 6
UZ - Uzbekistan 6
AU - Australia 5
EC - Ecuador 5
AE - Emirati Arabi Uniti 4
IL - Israele 4
JO - Giordania 4
KE - Kenya 4
LR - Liberia 4
LT - Lituania 4
NG - Nigeria 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
CL - Cile 3
CO - Colombia 3
DO - Repubblica Dominicana 3
GR - Grecia 3
NZ - Nuova Zelanda 3
PE - Perù 3
RO - Romania 3
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EG - Egitto 2
MY - Malesia 2
NI - Nicaragua 2
PY - Paraguay 2
SI - Slovenia 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IM - Isola di Man 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
NP - Nepal 1
PK - Pakistan 1
PT - Portogallo 1
RE - Reunion 1
RS - Serbia 1
SA - Arabia Saudita 1
SN - Senegal 1
TN - Tunisia 1
Totale 13.583
Città #
Warsaw 2.175
Woodbridge 1.328
Ashburn 677
Fairfield 641
Singapore 451
Chandler 432
Ann Arbor 282
Seattle 270
Jacksonville 269
Houston 261
Dallas 256
Wilmington 214
Cambridge 205
Hong Kong 204
Dublin 168
New York 139
Venezia 135
Beijing 134
Jinan 97
Boardman 88
Toronto 88
Shenyang 77
Venice 73
Council Bluffs 64
Hefei 64
Nanjing 63
Munich 62
Guangzhou 60
Mestre 60
Padova 60
Jakarta 58
Boston 55
Los Angeles 54
Dearborn 53
Ottawa 51
Andover 48
Hebei 45
Mülheim 42
San Mateo 42
Milan 39
Princeton 37
Tianjin 37
The Dalles 36
Zhengzhou 35
Bengaluru 34
San Diego 33
Seoul 33
Hangzhou 31
Changsha 30
Izmir 30
Tokyo 27
Brussels 25
Frankfurt am Main 25
Haikou 25
Nanchang 25
Ningbo 25
Santa Clara 24
Taiyuan 24
Altamura 23
Dong Ket 21
Helsinki 21
Ho Chi Minh City 21
London 21
São Paulo 21
Taizhou 21
Moscow 20
Phoenix 19
Turku 18
Columbus 17
Hanoi 16
Kraków 16
Redwood City 16
Brooklyn 15
Buffalo 15
Casablanca 15
Nuremberg 15
Redondo Beach 15
Fuzhou 13
Montreal 13
Saint Petersburg 13
Washington 13
Chicago 11
Orem 11
San Paolo di Civitate 11
Denver 10
Shanghai 10
Vienna 10
Des Moines 9
Jiaxing 9
Johannesburg 9
Poplar 9
Rio de Janeiro 9
Zurich 9
Bologna 8
Cotonou 8
Eraclea 8
Lanzhou 8
Mexico City 8
Monsummano Terme 8
Norwalk 8
Totale 10.691
Nome #
Addition of halogens and interhalogens on palladacyclopentadienyl complexes stabilized by pyridyl-thioether N-S spectator ligands 530
The addition of halogens and interhalogens on palladacyclopentadienyl complexes bearing quinolyl-thioether as spectator ligands. A kinetic and computational study 526
The unexpected case of reactions of halogens and interhalogens with halide substituted Pd(II) sigma-butadienyl complexes 516
Synthesis, characterization and a reactivity study of some allyl palladium complexes bearing bidentate hemi-labile carbene or mixed carbene/PPh3 ligands 486
The addition of bromine and iodine to palladacyclopentadienyl complexes bearing bidentate heteroditopic P-N spectator ligands derived from differently substituted quinolinic frames. The unexpected evolution of the reaction 484
Oxidative addition of organic halides on palladium(0) complexes stabilized by dimethylfumarate and quinoline-based N-P or N-S spectator ligands 480
Reactions of palladium(0) olefin complexes stabilized by some different hetero- and homo-ditopic spectator ligands with propargyl halides 456
Synthesis and characterization of palladacyclopentadiene complexes with N-heterocyclic carbene ligands 453
Reactivity of N-heterocyclic carbene-pyridine palladacyclopentadiene complexes toward halogen addition. the unpredictable course of the reaction 421
Synthesis of new allyl palladium complexes bearing purine-based NHC ligands with antiproliferative and proapoptotic activity on human ovarian cancer cell lines 421
Palladacyclopentadienyl complexes bearing purine-based N-heterocyclic carbenes: A new class of promising antiproliferative agents against human ovarian cancer 389
Synthesis and reactivity toward olefin exchange and oxidative addition of some platinum(0) olefin complexes with thioquinolines as spectator ligands 383
A simple and alternative way for the methylation of functionalized purine bases 381
Computational investigations on the unexpected extrusion of molecular iodine in Pd(II) σ-butadienyl complexes 377
Halogen metathesis in Pd(II) σ-butadienyl complexes 375
Synthesis and characterization of novel olefin complexes of palladium(0) with chelating bis(N-heterocyclic carbenes) as spectator ligands 373
Isocyanide insertion across the Pd–C bond of allenyl and propargyl palladium complexes bearing phosphoquinoline as a spectator ligand. Synthesis of a palladium complex bearing a coordinated cyclobutenyl fragment 372
The anticancer activity of an air-stable Pd(i)-NHC (NHC = N-heterocyclic carbene) dimer 359
Synthesis and in-depth studies on the anticancer activity of novel palladacyclopentadienyl complexes stabilized by N-Heterocyclic carbene ligands 343
Synthesis of novel olefin complexes of palladium(0) bearing monodentate NHC, phosphine and isocyanide spectator ligands 338
Chemoselective oxidative addition of vinyl sulfones mediated by palladium complexes bearing picolyl-N-heterocyclic carbene ligands 308
Synthesis, characterization and antiproliferative activity of theophyllinebased Pd(II) allyl complexes 297
Palladium (0) olefin complexes bearing purine-based N-heterocyclic carbenes and 1,3,5-triaza-7-phosphaadamantane (PTA): Synthesis, characterization and antiproliferative activity toward human ovarian cancer cell lines 286
Allyl palladium complexes bearing carbohydrate-based N-heterocyclic carbenes: Anticancer agents for selective and potent in vitro cytotoxicity 269
Improved Synthesis, Anticancer Activity and Electrochemical Characterization of Unusual Zwitterionic Palladium Compounds with a Ten‐Term Coordinative Ring 268
Synthesis of novel allyl palladium complexes bearing purine based NHC and a water soluble phosphine and their catalytic activity in the Suzuki-Miyaura coupling in water 261
Palladium(II)-η3-Allyl Complexes Bearing N-Trifluoromethyl N-Heterocyclic Carbenes: A New Generation of Anticancer Agents that Restrain the Growth of High-Grade Serous Ovarian Cancer Tumoroids 241
A critical review of palladium organometallic anticancer agents 220
The importance of the electronic and steric features of the ancillary ligands on the rate of cis–trans isomerization of olefins coordinated to palladium(0) centre. A study involving (Z)-1,2-ditosylethene as olefin model 218
Synthesis and comparative study of the anticancer activity of η3-allyl palladium(II) complexes bearing N-heterocyclic carbenes as ancillary ligands 181
Antibody Drug Conjugates for Cancer Therapy: From Metallodrugs to Nature-Inspired Payloads 167
Imidazo[1,5-a]pyridine-3-ylidenes and dipyridoimidazolinylidenes as ancillary ligands in Palladium allyl complexes with potent in vitro anticancer activity 160
Measuring the Olefin-to-Pd(0) Bond Strength: A Kinetic Study Involving Olefin Exchange Reactions on Palladium(0) Complexes Bearing Isocyanide Ligands 144
Cationic palladium(II)-indenyl complexes bearing phosphines as ancillary ligands: synthesis, and study of indenyl amination and anticancer activity 143
Mononuclear and dinuclear gold(i) complexes with a caffeine-based di(N-heterocyclic carbene) ligand: synthesis, reactivity and structural DFT analysis 130
A Green Synthesis of Carbene-Metal-Amides (CMAs) and Carboline-Derived CMAs with Potent in vitro and ex vivo Anticancer Activity 127
Indenyl and Allyl Palladate Complexes Bearing N ???Heterocyclic Carbene Ligands: an Easily Accessible Class of New Anticancer Drug Candidates 118
Biological and Catalytic Applications of Pd(II)-Indenyl Complexes Bearing Phosphine and N-Heterocyclic Carbene Ligands 116
Synthesis, characterization and anticancer activity of palladium allyl complexes bearing benzimidazole-based N-heterocyclic carbene (NHC) ligands 116
Synthesis, characterization, and anticancer activity of ferrocenyl complexes bearing different organopalladium fragments 113
Synthesis and anticancer activity of Pt(0)-olefin complexes bearing 1,3,5-triaza-7-phosphaadamantane and N-heterocyclic carbene ligands 109
A simple synthetic entryway into new families of NHC-gold-amido complexes and their in vitro antitumor activity 107
Gold(I)-N-Heterocyclic Carbene Synthons in Organometallic Synthesis 103
Synthesis, in silico and in vitro Evaluation of Novel Oxazolopyrimidines as Promising Anticancer Agents 97
Unveiling the promising anticancer activity of palladium(ii)–aryl complexes bearing diphosphine ligands: a structure–activity relationship analysis 93
Palladium(II)‐Imidoyl Complexes: A New Piece in the Puzzle of Organopalladium Anticancer Agents 87
Rational Design of Palladium(II) Indenyl and Allyl Complexes Bearing Phosphine and Isocyanide Ancillary Ligands with Promising Antitumor Activity 85
Palladium(II)-Indenyl Complexes Bearing N-Heterocyclic Carbene (NHC) Ligands as Potent and Selective Metallodrugs toward High-Grade Serous Ovarian Cancer Models 83
Platinum(0)-η2-1,2-(E)ditosylethene Complexes Bearing Phosphine, Isocyanide and N-Heterocyclic Carbene Ligands: Synthesis and Cytotoxicity towards Ovarian and Breast Cancer Cells 82
Synergistic applications of cyclodextrin-based systems and metal–organic frameworks in transdermal drug delivery for skin cancer therapy 79
Combined Treatment of Cancer Cells Using Allyl Palladium Complexes Bearing Purine-Based NHC Ligands and Molecules Targeting MicroRNAs miR-221-3p and miR-222-3p: Synergistic Effects on Apoptosis 79
Reactions of proteins with a few organopalladium compounds of medicinal interest 70
Recent Advances in Bioconjugated Transition Metal Complexes for Cancer Therapy 70
Reactivity of Palladium(II)-η3-Allyl Complexes with Chalcogenolates: A Density Functional Study of Their Antitumor Implications 61
Liposomal Formulations of Metallodrugs for Cancer Therapy 59
Synthesis and Anticancer Properties of Heterobimetallic Fe(II)/Pd(II) Complexes Bearing Different Butadienyl Fragments 58
Synthesis and Anticancer Activity of Palladium‐Butadienyl Complexes Bearing Picolyl‐NHC and Phosphine Ligands 55
Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapy 14
Mannose‐Inspired Mesoionic Carbenes: Building Antitumor Palladium(II) Allyl Complexes 13
Investigation of the in vitro anticancer potential of bis(imino)acenaphthene–N-heterocyclic carbene transition metal complexes revealed TrxR inhibition and triggering of immunogenic cell death (ICD) for allyl palladates 11
Synthesis of Gold(I) and Palladium(II) Complexes Bearing N‐Heterocyclic Carbene Thioglucosides with Selective Cytotoxicity Towards Ovarian Cancer Cells 10
Influence of the charge of 1,3,5-triaza-7-phosphaadamantane-based ligands on the anticancer activity of organopalladium complexes 10
Exploring the anticancer properties of indenyl and allyl palladates through their interaction with nucleic acids 6
Totale 13.787
Categoria #
all - tutte 42.032
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.032


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.296 0 0 0 0 0 147 164 121 168 246 265 185
2021/20221.959 165 151 116 264 152 12 55 121 25 188 571 139
2022/20231.153 77 133 12 148 114 309 27 77 135 12 85 24
2023/2024711 38 43 23 34 112 176 10 41 67 13 64 90
2024/20251.349 19 45 106 108 84 117 125 116 169 123 221 116
2025/20262.189 316 309 463 371 616 114 0 0 0 0 0 0
Totale 13.787